These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


397 related items for PubMed ID: 18949995

  • 21. [Hypereosinophilic syndrome--recent developments in diagnosis and treatment].
    Hellmich B, Holl-Ulrich K, Gross WL.
    Dtsch Med Wochenschr; 2007 Sep; 132(37):1892-6. PubMed ID: 17823882
    [Abstract] [Full Text] [Related]

  • 22. Successful treatment of refractory idiopathic hypereosinophilic syndrome with etoposide.
    Razaq W, Beautyman E.
    Am J Ther; 2009 Sep; 16(1):68-70. PubMed ID: 19142161
    [Abstract] [Full Text] [Related]

  • 23. Recent advances in pathogenesis and management of hypereosinophilic syndromes.
    Roufosse F, Cogan E, Goldman M.
    Allergy; 2004 Jul; 59(7):673-89. PubMed ID: 15180753
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Imatinib mesylate for the treatment of hypereosinophilic syndromes.
    Antoniu SA.
    Curr Opin Investig Drugs; 2006 Nov; 7(11):980-4. PubMed ID: 17117585
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Diagnosis of non-parasitic hypereosinophilia].
    Kahn JE, Girszyn N, Blétry O.
    Presse Med; 2006 Jan; 35(1 Pt 2):144-52. PubMed ID: 16462679
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management.
    Gotlib J.
    Am J Hematol; 2015 Nov; 90(11):1077-89. PubMed ID: 26486351
    [Abstract] [Full Text] [Related]

  • 31. Clinical approach to the patient with blood eosinophilia.
    Di Stefano F, Amoroso A.
    Eur Ann Allergy Clin Immunol; 2005 Dec; 37(10):380-6. PubMed ID: 16528901
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Hypereosinophilic syndrome and proliferative diseases.
    Ionescu MA, Wang L, Janin A.
    Acta Dermatovenerol Croat; 2009 Dec; 17(4):323-30. PubMed ID: 20021987
    [Abstract] [Full Text] [Related]

  • 35. [Alpha interferon treatment in idiopathic hypereosinophilic syndrome resistant to conventional therapy].
    Esteve J, Cervantes F, Bosch F, Cobo F, Montserrat E, Rozman C.
    Med Clin (Barc); 1996 Mar 02; 106(8):304-6. PubMed ID: 8667689
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Neurologic complications in hypereosinophilia syndrome--a case report].
    Otto V.
    Fortschr Neurol Psychiatr; 1993 Sep 02; 61(9):310-2. PubMed ID: 7693561
    [Abstract] [Full Text] [Related]

  • 38. [A case of idiopathic hypereosinophilic syndrome with hepatic involvement in a 5-year-old boy].
    Kim YM, Lee YJ, Park JH, Lee JW, Lee CH.
    Taehan Kan Hakhoe Chi; 2002 Sep 02; 8(3):321-6. PubMed ID: 12499791
    [Abstract] [Full Text] [Related]

  • 39. Löffler's endomyocarditis in the idiopathic hypereosinophilic syndrome.
    Corssmit EP, Trip MD, Durrer JD.
    Cardiology; 1999 Sep 02; 91(4):272-6. PubMed ID: 10545685
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 20.